Epigenetic Modifications: Therapeutic Potential in Cancer

Epigenetic Modifications: Therapeutic Potential in Cancer

Epigenetic modifications and alterations in chromatin structure and function contribute to the cumulative changes observed as normal cells undergo malignant transformation. These modifications and enzymes (DNA methyltransferases, histone deacetylases, histone methyltransferases, and demethylases) re...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Manisha Sachan, Manpreet Kaur
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Instituto de Tecnologia do Paraná (Tecpar) 2015-08-01
Reeks:	Brazilian Archives of Biology and Technology
Onderwerpen:	HDAC inhibitors Cancer epigenetics Histone modification
Online toegang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132015000400526&lng=en&tlng=en

Gelijkaardige items

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
door: Michelle Esposito, et al.
Gepubliceerd in: (2019-05-01)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
door: Guo Li, et al.
Gepubliceerd in: (2020-09-01)

Implication des modifications épigénétiques dans les cancers : développement de nouvelles approches thérapeutiques
door: Willems L., et al.
Gepubliceerd in: (2008-01-01)

Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
door: Xiaomin Wang, et al.
Gepubliceerd in: (2023-06-01)

Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
door: Delcuve Geneviève P, et al.
Gepubliceerd in: (2012-03-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
door: Dineo eKhabele
Gepubliceerd in: (2014-05-01)

dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation
door: Mohammad Mijanur Rahman, et al.
Gepubliceerd in: (2024-12-01)

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
door: Qingfan Yang, et al.
Gepubliceerd in: (2022-01-01)

Epigenetic regulation by gut microbiota
door: Vivienne Woo, et al.
Gepubliceerd in: (2022-12-01)

Epigenetic modification enzymes: catalytic mechanisms and inhibitors
door: Duo Lu
Gepubliceerd in: (2013-05-01)

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
door: Dusan Ruzic, et al.
Gepubliceerd in: (2022-01-01)

Epigenetic control of the vicious cycle
door: Madeline B. Searcy, et al.
Gepubliceerd in: (2024-02-01)

The role of HDAC3 in inflammation: mechanisms and therapeutic implications
door: Noah Watson, et al.
Gepubliceerd in: (2024-07-01)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
door: Yu Wang, et al.
Gepubliceerd in: (2022-05-01)

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
door: Flavia Lima Costa Faldoni, et al.
Gepubliceerd in: (2020-05-01)

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
door: Xilan Yu, et al.
Gepubliceerd in: (2018-09-01)

Histones and their modifications in ovarian cancer – drivers of disease and therapeutic targets
door: Deborah Joy Marsh, et al.
Gepubliceerd in: (2014-06-01)

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS
door: V. P. Maksimova, et al.
Gepubliceerd in: (2020-09-01)

From Bench to Bedside: Targeting Epigenetics for Cancer Therapy
door: Jin-xu Fang, et al.
Gepubliceerd in: (2011-12-01)

Mechanisms and technologies in cancer epigenetics
door: Zaki A. Sherif, et al.
Gepubliceerd in: (2025-01-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
door: Kelly N. Hassell
Gepubliceerd in: (2019-11-01)

Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
door: Ibrahim S. Alalhareth, et al.
Gepubliceerd in: (2025-02-01)

Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
door: Louis Legoff, et al.
Gepubliceerd in: (2021-08-01)

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
door: Hana Q. Sadida, et al.
Gepubliceerd in: (2024-01-01)

The proteasome and epigenetics: zooming in on histone modifications
door: Bach Svitlana V., et al.
Gepubliceerd in: (2016-08-01)

New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
door: Yi Luan, et al.
Gepubliceerd in: (2022-04-01)

Epigenetics modifications and therapeutic prospects in human thyroid cancer
door: Maria Graziella eCatalano, et al.
Gepubliceerd in: (2012-03-01)

Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus
door: Xiaojie Wang, et al.
Gepubliceerd in: (2012-08-01)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
door: Vera Miranda-Gonçalves, et al.
Gepubliceerd in: (2018-10-01)

Connections between metabolism and epigenetic modifications in cancer
door: Wang Guangchao, et al.
Gepubliceerd in: (2021-12-01)

Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
door: Wenjing Xiao, et al.
Gepubliceerd in: (2021-09-01)

Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
door: Srinivas Patnaik, et al.
Gepubliceerd in: (2019-06-01)

Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
door: Maria R. Pozo, et al.
Gepubliceerd in: (2022-01-01)

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
door: Vera Miranda-Gonçalves, et al.
Gepubliceerd in: (2019-09-01)

Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia
door: Abhinav Dhall, et al.
Gepubliceerd in: (2019-05-01)

Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities
door: Reyhaneh Farrokhi Yekta, et al.
Gepubliceerd in: (2024-10-01)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
door: Reem Saleh, et al.
Gepubliceerd in: (2020-07-01)

Epigenetic Modifications of Host Genes Induced by Bacterial Infection
door: Maryam Parhamfar, et al.
Gepubliceerd in: (2021-08-01)

NSD family proteins: Rising stars as therapeutic targets
door: Lin He, et al.
Gepubliceerd in: (2024-04-01)

Pulmonary Pathogen-Induced Epigenetic Modifications
door: Dylan Wrede, et al.
Gepubliceerd in: (2023-07-01)